Comparing the adverse effects of ketamine and esketamine between genders using FAERS data
BackgroundKetamine was developed as an anesthetic. Esketamine is the isolated S-enantiomer of racemic ketamine. They provide new avenues for the treatment of depression, especially treatment-resistant depression. Considering differences in the pharmacokinetics and hormonal status of ketamine in pati...
Saved in:
Main Authors: | Xinxia Yang (Author), Dongdong Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine
by: Xiaofan Ma, et al.
Published: (2023) -
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
by: Fabrice Jollant, et al.
Published: (2023) -
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
by: Simone Pardossi, et al.
Published: (2024) -
The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023) -
Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis
by: Na Zhou, et al.
Published: (2023)